If constipation, nausea, bloating, or poor intake keeps going, that's the point to involve your clinician rather than trying to out-supplement the problem on your own
Its a prescription medication classified as a glucagon-like peptide-1 (GLP-1) receptor agonist
That has officially changed
That made direct comparisons imprecise at best and misleading at worst
These medications may be appropriate for acute pain, neuropathic pain, or specific conditions as per NICE guidance, but require individual assessment, careful monitoring, and time-limited use
This is why CJC-1295 and Ipamorelin research should not be collapsed into one generic peptide topic